Failure to Monitor Antipsychotic Behaviors and Side Effects
Summary
The facility failed to ensure that residents receiving antipsychotic medications were monitored for behaviors and side effects. For Resident #15, staff observed behaviors including yelling, refusing care, refusing to get out of bed, voiding on herself, and covering her head with her shirt. The resident had diagnoses including unspecified psychosis, dementia with behavioral disturbance, schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder, and generalized anxiety disorder. She was receiving aripiprazole 20 mg daily, and the physician order required behavior monitoring and documentation of side effects every shift, but the behavior monitoring record contained no entries from 11/01/2025 through 02/11/2026. Resident #15’s record also showed care plan focuses for behavioral symptoms and psychotropic medication use, with interventions to observe and document side effects and effectiveness, document behavior episodes, and report changes such as insomnia, nervousness, loss of interest, decreased concentration, repetitive movements, and other antipsychotic side effects. Staff interviews showed that CNAs and an RN were aware the resident had behaviors such as yelling, refusing care, and refusing to comply with dressing and changing, but the RN stated these refusals were not documented because they were not extreme or aggressive. The RN also stated there were no expectations for CNAs to perform the ordered monitoring, and that behaviors and side effects should have been documented regardless of whether the resident presented with behaviors. For Resident #17, the record showed diagnoses including mixed receptive-expressive language disorder, bipolar disorder with psychotic features, generalized anxiety disorder, and dementia. The resident was prescribed haloperidol 1 mg daily, haloperidol 2 mg in the evening, trazodone 50 mg at bedtime, and trihexyphenidyl 4 mg three times daily. No orders were found for behavior monitoring or side effect monitoring. The care plan included psychotropic medication use with goals for minimal side effects and interventions to observe and document side effects and effectiveness, but the record did not show the required monitoring. Psychiatry notes documented ongoing psychosis, mania, depression, and dementia, and specifically stated to monitor for adverse effects of haloperidol, particularly dyskinesia and extrapyramidal symptoms. Staff interviews indicated that monitoring was expected, but the DON stated monitoring was done by the team and psych provider, while other staff described inconsistent understanding of who was responsible for documenting behaviors and medication side effects.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.